The Senate committee advanced Dr. Erica Schwartz’s nomination to lead the Centers for Disease Control and Prevention (CDC). Her confirmation by the full Senate is pending. Schwartz faces concerns regarding her ability to resist political interference.
Schwartz’s Background and Nomination Process
If confirmed, Schwartz will become the 22nd director of the CDC. Her qualifications include medical and law degrees, serving as a deputy surgeon general, and a leadership role in the U.S. Coast Guard.
Despite initial doubts expressed during a Senate hearing, Senate Health, Education, Labor and Pensions Committee Chairman, Sen. Bill Cassidy, R-La., endorses her. Cassidy, after further discussions with Schwartz and others, expressed confidence in her judgment.
Concerns Over Political Influence
Committee members, such as Sen. Bernie Sanders, raised concerns about Schwartz standing up to President Trump’s health secretary, Robert F. Kennedy Jr., against unscientific directives. Kennedy, known for opposing vaccines, has previously attempted to change vaccine guidelines.
The CDC has faced challenges under Trump’s leadership, including significant staff reductions. Schwartz’s nomination led to cautious optimism among public health experts due to her credentials and detachment from Kennedy’s anti-vaccine stance.
Public Health Advocacy and Scrutiny
During Schwartz’s hearing, public health groups highlighted the need for assurance on scientific independence and evidence-based policymaking. Despite Schwartz’s commitment to science, some criticized her responses as lacking specificity.
Dr. Georges Benjamin from the American Public Health Association and Dr. Daniel Jernigan, a former CDC official, support Schwartz’s nomination. They see her as pivotal in rebuilding CDC’s structure and public trust.
Nomination History and Other Leadership Vacancies
Schwartz is the third Trump nominee for the CDC director position in 18 months. Previous nominees faced significant hurdles, with meetings canceled and confirmed acting directors removed shortly after appointment.
Besides the CDC, several leadership positions in federal health agencies remain vacant. The Senate committee also moved forward with the nomination of Sean Kaufman for Assistant Health Secretary for Preparedness and Response, despite controversy over his stance on vaccines.
Sen. Cassidy remains hopeful about administrative changes ensuring decisions driven by science. However, Sen. Sanders expressed disapproval of Trump’s nominations, advocating for better candidates.
The Associated Press Health and Science Department benefits from support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP remains solely responsible for its content.